U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: September 8-14, 2019
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: September 8-14, 2019

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Norman E. Sharpless, M.D. (Acting), Commissioner of Food and Drugs

Event Date: 09/10/2019
Location: Gaithersburg, MD
Subject: FDA Patient Engagement Advisory Committee: Cybersecurity in Medical Devices
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Government, industry, academia, media and the general public

Event Date: 09/12/2019
Location: Silver Spring, MD
Subject: Infectious Diseases Society of America: Antimicrobial Resistance and the Antibiotic Pipeline
FDA Participant/Group: HEIDI REBELLO; KRISTINE MORAN; STACY AMIN; KATHERINE SCHUMANN; MARION GRUBER; EMILY HELMS WILLIAMS; TIMOTHY STENZEL; CELIA SILVERMAN; DENNIS HINTON; STEVEN SOLOMON; KEAGAN LENIHAN; JOHN FARLEY;
Non FDA Participant/Group: Amanda Jezek, Helen Boucher, Vance Fowler (Infectious Diseases Society of America); Sue Ramthun (Hart Health Strategies);

Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Lowell J. Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 09/09/2019
Location: Albuquerque, NM
Subject: 2019 Annual Meeting: National Association of State Departments of Agriculture: Partnering to Keep Produce Safe
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, and other registered guests

Event Date: 09/11/2019
Location: Mexico City, Mexico
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: ANA LILIA SANDOVAL; KENNETH NIEVES; DOUGLAS STEARN; MICHELLE RODRIGUEZ; DONALD PRATER; KATHERINE SERRANO;
Non FDA Participant/Group: Amada Vélez Mendez, Javier Trujillo Arriaga, José Luis Lara (National Service for Animal and Plant Health, Food Safety and Quality, Mexico);

Event Date: 09/11/2019
Location: Mexico City, Mexico
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: KATHERINE SERRANO; DONALD PRATER; ANA LILIA SANDOVAL; KENNETH NIEVES; DOUGLAS STEARN; MICHELLE RODRIGUEZ;
Non FDA Participant/Group: Alejandro Nieto Rodríguez, Angélica Garcia Otamendi, Armida Zuñiga Estrada, José Alonso Novelo Baeza (Federal Commission for the Protection Against Sanitary Risk, Mexico);

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

Event Date: 09/09/2019
Location: Rockville, MD
Subject: Clinical Trials Transformation Initiative (CTTI): Strategic Retreat
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Event Date: 09/09/2019
Location: Silver Spring, Md
Subject: Duchenne Muscular Dystrophy Platform Trial Stakeholder Meeting: Platform Trials in Rare Disease
FDA Participant/Group: WILLIAM DUNN;
Non FDA Participant/Group: Ed Connor (Institute for Advance Clinical Trials for Children); Abby Bronson (Parent Project Muscular Dystrophy); Jane Larkindale (Critical Path Institute);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 09/14/2019
Location: Washington, DC
Subject: National Hemophilia Foundation (NHF) 15th Workshop: Novel Technologies and Gene Transfer for Hemophilia: FDA Guidance on the Development of Products for Hemophilia
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

Event Date: 09/09/2019
Location: Utrecht, Netherlands
Subject: Global Tobacco Regulators Forum (GTRF)
FDA Participant/Group: CAITLIN ADDORISIO;
Non FDA Participant/Group: Several attendees from the world health organization and the Global Tobacco Regulators forum

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 09/10/2019
Location: Rockville, MD
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: SIOBHAN DELANCEY; NEAL BATALLER; ASHLEY STEEL; HEATHER TATE; WILLIAM FLYNN;
Non FDA Participant/Group: Several members from the Pew Charitable Trusts organization

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event